Increased iron requirement in hemodialysis patients on antiplatelet agents or warfarin

Nephron - Clinical Practice

Volumn 113, Issue 1, 2009, Pages

  Flint, Shaun ^a   Taylor, Emma ^a   Beavis, Jennifer ^a   Becker, Gavin J ^a   Pedagogos, Eugenie ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Anemia; Anticoagulation; Antiplatelet agent; Hemodialysis; Iron

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CLOPIDOGREL; ENOXAPARIN; FERRIC HYDROXIDE SUCROSE; FERRITIN; HEPARIN; IRON; IRON POLYMALTOSE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; WARFARIN;

ADD ON THERAPY; ADULT; AGED; ANTICOAGULANT THERAPY; ARTERIOVENOUS FISTULA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE TITRATION; FEMALE; FERRITIN BLOOD LEVEL; GASTROINTESTINAL HEMORRHAGE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME; VASCULAR DISEASE;

AGE FACTORS; AGED; ANEMIA, IRON-DEFICIENCY; C-REACTIVE PROTEIN; COMORBIDITY; DIABETIC NEPHROPATHIES; FEMALE; FERRIC COMPOUNDS; FERRITINS; HEMORRHAGE; HUMANS; INFLAMMATION; IRON; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NUTRITIONAL REQUIREMENTS; PLATELET AGGREGATION INHIBITORS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; THROMBOPHILIA; TRANSFERRIN; VASCULAR DISEASES; WARFARIN;

EID: 67649834466     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228074     Document Type: Article

References (12)

1. McQuaid KR, Laine L: Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med 2006;119:624-638. (Pubitemid 44128438)
2. Holden RM, Harman GJ, Wang M, Holland D, Day AG: Major bleeding in hemodialysis patients. Clin J Am Soc Nephrol 2008;3:105-110.
3. Elliott MJ, Zimmerman D, Holden RM: Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates. Am J Kidney Dis 2007;50:433-440. (Pubitemid 47285456)
4. Kaw D, Malhotra D: Platelet dysfunction and end-stage renal disease. Semin Dial 2006;19:317-322. (Pubitemid 44091707)
5. Roger S: The CARI guidelines. Haematological targets. Iron. Nephrology (Carlton) 2006;11(suppl 1):S217-S229.
6. Pollock C, McMahon L: The CARI guidelines. Biochemical and haematological targets guidelines. Haemoglobin. Nephrology (Carlton) 2005;10(suppl 4):S108-S115.
7. Goicoechea M, Caramelo C, Ochando A, Andrea C, Garvia R, Ortiz A: Antiplatelet therapy alters iron requirements in hemodialysis patients. Am J Kidney Dis 2000;36:80-87. (Pubitemid 30432568)
8. Chalasani N, Cotsonis G, Wilcox CM: Upper gastrointestinal bleeding in patients with chronic renal failure: role of vascular ectasia. Am J Gastroenterol 1996;91:2329-2332. (Pubitemid 26383195)
9. Brewster UC: Intravenous iron therapy in end-stage renal disease. Semin Dial 2006;19:285-290. (Pubitemid 44091702)
10. Wasse H, Gillen DL, Ball AM, Kestenbaum BR, Seliger SL, Sherrard D, Stehman-Breen CO: Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients. Kidney Int 2003;64:1455-1461. (Pubitemid 37153813)
11. Yeomans ND, Lanas AI, Talley NJ, Thomson AB, Daneshjoo R, Eriksson B, Appelman-Eszczuk S, Langstrom G, Naesdal J, Serrano P, Singh M, Skelly MM, Hawkey CJ: Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther 2005;22:795-801. (Pubitemid 41564359)
12. Ethier J, Bragg-Gresham JL, Piera L, Akizawa T, Asano Y, Mason N, Gillespie BW, Young EW: Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2007;50:602-611. (Pubitemid 47444460)